Datos a fecha 13/05/26 03:24
| Ticker | TMDX |
|---|---|
| ISIN | US89377M1099 |
| Sector | Tecnología |
| Industria | Medical - Devices |
| Mercado | NASDAQ |
| Capitalización | 2.519.489.610 US$ |
| Beta | 2,06 |
| Sitio web | https://www.transmedics.com |
| CEO | Waleed H. Hassanein |
| Fecha de IPO | 02/05/2019 |
| País | US |
| Dirección | 200 Minuteman Road, Andover, MA, 01810 |
| Volumen | 2.579.151 |
Sobre TransMedics Group, Inc: TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the...
El precio actual de las acciones de TransMedics Group, Inc (TMDX) es de 63,93 , con una variación del -0,58%.
Las acciones de TransMedics Group, Inc cotizan en la bolsa de valores NASDAQ.
El símbolo bursátil de TransMedics Group, Inc es "TMDX".
TransMedics Group, Inc no paga dividendos.
La capitalización de mercado de TransMedics Group, Inc es 2.342.917.972 .
TransMedics Group, Inc opera en el sector Healthcare, industria Medical - Devices.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones